Literature DB >> 12964417

A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding.

Ritu Khurana1, Pierre O Souillac, Alisa C Coats, Lauren Minert, Cristian Ionescu-Zanetti, Sue A Carter, Alan Solomon, Anthony L Fink.   

Abstract

In an attempt to understand the mechanism of amyloid fibril formation in light chain amyloidosis, the properties of amyloidogenic (SMA) and benign (LEN) immunoglobulin light chain variable domains (VL) were compared. The conformations of LEN and SMA were measured using secondary and tertiary structural probes over the pH range from 2 and 8. At all pH values, LEN was more stable than SMA. The CD spectra of LEN at pH 2 were comparable to those of SMA at pH 7.5, indicating that the low pH conformation of LEN closely resembles that of SMA at physiological pH. At low pH, a relatively unfolded intermediate conformation is populated for SMA and rapidly leads to amyloid fibrils. The lack of such an intermediate with LEN, is attributed to sequence differences and accounts for the lack of LEN fibrils in the absence of agitation. A kappa IV-specific monoclonal antibody that recognizes the N-terminal of SMA caused unraveling of the fibrils to the protofilaments and was observed to bind to one end of SMA protofilaments by atomic force microscopy. The antibody result indicates that each protofilament is asymmetric with different ends. A model for the formation of fibrils by SMA is proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964417     DOI: 10.3109/13506120309041731

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  8 in total

1.  The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA.

Authors:  Xiaoyun Meng; Anthony L Fink; Vladimir N Uversky
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

2.  Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.

Authors:  Brian O'Nuallain; Amy Allen; Stephen J Kennel; Deborah T Weiss; Alan Solomon; Jonathan S Wall
Journal:  Biochemistry       Date:  2007-02-06       Impact factor: 3.162

Review 3.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

Review 4.  Amyloid formation in light chain amyloidosis.

Authors:  Marina Ramirez-Alvarado
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

5.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

6.  Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.

Authors:  Sujoy Mukherjee; Simon P Pondaven; Kieran Hand; Jillian Madine; Christopher P Jaroniec
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

7.  Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.

Authors:  Emily B Martin; Angela Williams; Craig Wooliver; R Eric Heidel; Sarah Adams; John Dunlap; Marina Ramirez-Alvarado; Luis M Blancas-Mejia; Ronald H Lands; Stephen J Kennel; Jonathan S Wall
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

8.  Isolation and purification of recombinant immunoglobulin light chain variable domains from the periplasmic space of Escherichia coli.

Authors:  Kieran Hand; Mark C Wilkinson; Jillian Madine
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.